Please login to the form below
Ranbaxy wins FDA approval for Metformin in US
India-based Ranbaxy Laboratories' 100 per cent-owned Ohm Laboratories has won FDA approval to manufacture and market Metformin tablets in the US.
India-based Ranbaxy Laboratories' 100 per cent-owned Ohm Laboratories has won FDA approval to manufacture and market Metformin tablets in the US.
Ipca Laboratories, which has a strategic alliance with Ranbaxy, will manufacture the formulation at its facilities in India. Ranbaxy will commercialise the product in the US market, Ipca revealed in a press statement to the Bombay Stock Exchange.
Total annual US sales for Metformin, an insulin sensitising agent, was USD 379m, according to Ranbaxy.
Share
Related Hub content
Subscribe to our email news alerts
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
- Presenting Outstanding Outcomes from HCP Education in Multiple Myeloma at IMS in Athens
No results were found
PMHub
Redbow Consulting Group
Redbow Consulting Group is a specialist healthcare management consultancy specialising in business strategy and marketing...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
